MCOV B Intrinsic Valuation and Fundamental Analysis - Medicover AB - Alpha Spread

Medicover AB
STO:MCOV B

Watchlist Manager
Medicover AB Logo
Medicover AB
STO:MCOV B
Watchlist
Price: 191.6 SEK -0.73% Market Closed
Market Cap: 28.8B SEK
Have any thoughts about
Medicover AB?
Write Note

Intrinsic Value

The intrinsic value of one MCOV B stock under the Base Case scenario is 274.37 SEK. Compared to the current market price of 191.6 SEK, Medicover AB is Undervalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MCOV B Intrinsic Value
274.37 SEK
Undervaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medicover AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MCOV B cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MCOV B?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Medicover AB

Provide an overview of the primary business activities
of Medicover AB.

What unique competitive advantages
does Medicover AB hold over its rivals?

What risks and challenges
does Medicover AB face in the near future?

Summarize the latest earnings call
of Medicover AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medicover AB.

Provide P/S
for Medicover AB.

Provide P/E
for Medicover AB.

Provide P/OCF
for Medicover AB.

Provide P/FCFE
for Medicover AB.

Provide P/B
for Medicover AB.

Provide EV/S
for Medicover AB.

Provide EV/GP
for Medicover AB.

Provide EV/EBITDA
for Medicover AB.

Provide EV/EBIT
for Medicover AB.

Provide EV/OCF
for Medicover AB.

Provide EV/FCFF
for Medicover AB.

Provide EV/IC
for Medicover AB.

Show me price targets
for Medicover AB made by professional analysts.

What are the Revenue projections
for Medicover AB?

How accurate were the past Revenue estimates
for Medicover AB?

What are the Net Income projections
for Medicover AB?

How accurate were the past Net Income estimates
for Medicover AB?

What are the EPS projections
for Medicover AB?

How accurate were the past EPS estimates
for Medicover AB?

What are the EBIT projections
for Medicover AB?

How accurate were the past EBIT estimates
for Medicover AB?

Compare the revenue forecasts
for Medicover AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medicover AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medicover AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medicover AB compared to its peers.

Compare the P/E ratios
of Medicover AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Medicover AB with its peers.

Analyze the financial leverage
of Medicover AB compared to its main competitors.

Show all profitability ratios
for Medicover AB.

Provide ROE
for Medicover AB.

Provide ROA
for Medicover AB.

Provide ROIC
for Medicover AB.

Provide ROCE
for Medicover AB.

Provide Gross Margin
for Medicover AB.

Provide Operating Margin
for Medicover AB.

Provide Net Margin
for Medicover AB.

Provide FCF Margin
for Medicover AB.

Show all solvency ratios
for Medicover AB.

Provide D/E Ratio
for Medicover AB.

Provide D/A Ratio
for Medicover AB.

Provide Interest Coverage Ratio
for Medicover AB.

Provide Altman Z-Score Ratio
for Medicover AB.

Provide Quick Ratio
for Medicover AB.

Provide Current Ratio
for Medicover AB.

Provide Cash Ratio
for Medicover AB.

What is the historical Revenue growth
over the last 5 years for Medicover AB?

What is the historical Net Income growth
over the last 5 years for Medicover AB?

What is the current Free Cash Flow
of Medicover AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medicover AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medicover AB

Current Assets 425.6m
Cash & Short-Term Investments 88.7m
Receivables 270.7m
Other Current Assets 66.2m
Non-Current Assets 1.6B
Long-Term Investments 19.6m
PP&E 908m
Intangibles 653.8m
Other Non-Current Assets 30.6m
Current Liabilities 534.2m
Accounts Payable 217.8m
Other Current Liabilities 316.4m
Non-Current Liabilities 1B
Long-Term Debt 888m
Other Non-Current Liabilities 115.5m
Efficiency

Earnings Waterfall
Medicover AB

Revenue
1.9B EUR
Cost of Revenue
-1.5B EUR
Gross Profit
394.7m EUR
Operating Expenses
-316.9m EUR
Operating Income
77.8m EUR
Other Expenses
-54.7m EUR
Net Income
23.1m EUR

Free Cash Flow Analysis
Medicover AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In the second quarter, the company experienced robust organic revenue growth of 16.5%, contributing to a 20% overall increase. Poland and Germany led this growth, with revenues rising by 24% and 18% respectively. Operating leverage saw significant improvements, with EBITDA up 22%, EBITDAaL up 28%, and operating profit soaring by 45%. The company reaffirmed its confident outlook, projecting organic revenues to reach EUR 2.2 billion by 2025. Despite some challenges in the Indian market and recent hospital openings, overall financial targets remain well on track, supported by strong cash generation and prudent capital expenditure, now at 5% of revenue.

What is Earnings Call?
Fundamental Scores

MCOV B Profitability Score
Profitability Due Diligence

Medicover AB's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive 3-Years Revenue Growth
Positive Gross Profit
Positive Revenue Growth Forecast
Positive Free Cash Flow
49/100
Profitability
Score

Medicover AB's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

MCOV B Solvency Score
Solvency Due Diligence

Medicover AB's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
Average D/E
41/100
Solvency
Score

Medicover AB's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MCOV B Price Targets Summary
Medicover AB

There are no price targets for MCOV B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MCOV B?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Sep 27, 2024
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Want to learn more about MCOV B dividends?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for MCOV B is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Medicover AB Logo
Medicover AB

Country

Sweden

Industry

Health Care

Market Cap

28.8B SEK

Dividend Yield

0.06%

Description

Medicover AB engages in the provision of invitro diagnostics and healthcare services. The company is headquartered in Stockholm, Stockholm and currently employs 38,555 full-time employees. The company went IPO on 2017-05-23. The company offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The firm offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The firm focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.

Contact

STOCKHOLM
Stockholm
Riddargatan 12 A 3Tr
+468446461764646.0
www.medicover.com

IPO

2017-05-23

Employees

38 555

Officers

See Also

Discover More
What is the Intrinsic Value of one MCOV B stock?

The intrinsic value of one MCOV B stock under the Base Case scenario is 274.37 SEK.

Is MCOV B stock undervalued or overvalued?

Compared to the current market price of 191.6 SEK, Medicover AB is Undervalued by 30%.

Back to Top